GAR Capital Top 10 Stocks of 2025: 9-Month Update, Market Outperformance & Legendary Dip Buys

Carlos Garcia | Sep 16, 2025 |

GAR Capital Top 10 Stocks of 2025: 9-Month Update, Market Outperformance & Legendary Dip Buys

Summary

GAR Capital’s Top 10 Stocks of 2025 are all positive nine months into the year, led by triple-digit gains in HIMS and QBTS. Compared with the S&P 500 (+14% YTD) and Nasdaq (+18% YTD), our diversified basket has delivered superior returns. Key “Legendary Dip Buys” in Tesla, NVIDIA, HIMS, and Bitcoin during March–May supercharged performance. Read our updated scorecard and outlook heading into Q4 2025.

Market Recap

  • AMAZON ( AMZN ) : +1.56%
  • HIMS & HERS HEALTH ( HIMS ): -7.62%

Market Movers

No market movers this week..

📚 Deep Dive 📚

🚀 GAR Capital Top 10 Stocks of 2025 – Nine Months In

Back in January, we rolled out our Top 10 Stocks of 2025 — a diversified, growth-oriented basket designed to capture secular trends across healthcare, tech, energy, entertainment, and crypto.

Nine months later, every single name is in the green, with several delivering outsized triple-digit gains. This performance comes against a backdrop where the S&P 500 is up +14% YTD and the Nasdaq Composite is up +18% YTD.

Our portfolio hasn’t just kept pace — it’s been a consistent alpha generator, with multiple positions outpacing the broader market by a wide margin.

Here’s the scorecard and updated outlook as we push into Q4.


🏆 Scorecard: GAR Capital Top 10

Hims & Hers Health (HIMS) – +114% YTD
Our single biggest winner of 2025. Telehealth adoption and consumer wellness trends continue to compound. After this run, valuation is stretched — but we’re holding a core and only adding on healthy pullbacks.

D-Wave Quantum (QBTS) – +86% YTD
The moonshot play is paying off. Government and enterprise contracts are stacking up. Volatility remains high, but QBTS is proving its place as an “option on the future of computing.”

TKO Group (TKO) – +43% YTD
The UFC/WWE merger thesis is playing out exactly as expected. Media-rights negotiations in 2026 could be a major re-rating event.

VanEck Uranium ETF (NLR) – +46% YTD
The nuclear renaissance is real. Global demand and constrained supply have kept uranium prices trending higher. Still a core conviction hold.

NVIDIA (NVDA) – +27% YTD
The backbone of AI. While the valuation looks expensive, earnings continue to beat. A classic buy-the-dip stock for long-term portfolios.

Microsoft (MSFT) – +21% YTD
The “sleep-well” compounder. Azure growth + OpenAI integration keeps MSFT at the heart of cloud + AI. A steady anchor in the basket.

DraftKings (DKNG) – +25% YTD
Sports betting continues to scale. Expect NFL seasonality and 2026 World Cup hype to drive further momentum.

Tesla (TSLA) – +13% YTD
After a shaky H1, TSLA has stabilized. Energy storage and autonomy remain underappreciated. Option spreads remain our preferred play for leverage.

Amazon (AMZN) – +5% YTD
A late bloomer in 2025. AWS growth is reaccelerating, advertising is quietly strong. A holiday season tailwind could lift this higher into year-end.

Bitcoin – +23% YTD
Digital gold keeps shining. Spot ETF inflows and Fed policy remain the key catalysts.


📉 Legendary Dip Buys (March–May 2025)

While our basket started the year strong, the real alpha was generated during the spring selloff. March, April, and May gave us textbook opportunities:

  • Tesla dipped under $230 → now soaring above $420.
  • NVIDIA pulled back 20% → we doubled down bought more on April 7th at bear market bottom
  • HIMS retraced down to $20s and we bought more at $30
  • Bitcoin tested $72K before rocketing back to new cycle highs.

Those “Legendary Dip Buys” were the turning point that supercharged returns heading into the summer and today.


📊 Big Picture vs. the Market

  • S&P 500: +14% YTD
  • Nasdaq Composite: +18% YTD
  • GAR Capital Top 10: All ten names green, with multiple triple-digit winners.

Our basket is proof that selective sector exposure + tactical trading = outperformance.

Leadership rotated (HIMS & QBTS took the crown, while TSLA & AMZN are just waking up), yet the balanced mix across healthcare, AI, energy, entertainment, and crypto kept the portfolio resilient.


🔭 Looking Ahead

With the Fed signaling potential rate cuts into year-end, liquidity could remain a tailwind for risk assets.

Our plan:

  • Trim extended names with options premium selling.
  • Add on weakness in long-term secular winners.
  • Stay diversified across growth engines.

Nine months down, our 2025 Top 10 Portfolio is doing exactly what we envisioned: delivering strong, risk-adjusted returns in a choppy macro backdrop.

The mission now: keep momentum rolling through Q4 and close out 2025 even stronger.

Best Regards,

Carlos Garcia